Rapid genotyping of inversion variants in Mucopolysaccharidosis type II using long-range PCR: A case report
- PMID: 39282050
- PMCID: PMC11402328
- DOI: 10.1016/j.ymgmr.2024.101139
Rapid genotyping of inversion variants in Mucopolysaccharidosis type II using long-range PCR: A case report
Abstract
Mucopolysaccharidosis II (MPS II) is a lysosomal storage disease caused by a deficiency in iduronate-2-sulfatase (IDS), leading to the accumulation of dermatan sulfate and heparan sulfate in lysosomes. Traditionally, genotyping of the IDS gene has been conducted through exome sequencing, which fails to detect inversion variants. Consequently, when no pathogenic variants are detected in exons, additional PCR-based analysis is required. Herein, we introduce a rapid genotyping technique method using long-range PCR for MPS II patients. We successfully identified an inversion variant and confirmed the sequences of the inversion regions. We also confirmed that the pathogenic variant in the patient originated de novo. These findings suggest that long-range PCR genotyping can identify inversion variants more rapidly compared to the previous PCR-based methods, making it a valuable tool for newborn screening (NBS) and genetic diagnosis.
Keywords: IDS gene; Iduronate-2-sulfatase; Inversion variant; Long-range PCR; Mucopolysaccharidosis type II.
© 2024 The Authors. Published by Elsevier Inc.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures

References
-
- Muenzer J., Burton B.K., Amartino H.M., Harmatz P.R., Gutiérrez-Solana L.G., Ruiz-Garcia M., Wu Y., Merberg D., Alexanderian D., Jones S.A. Neurodevelopmental status and adaptive behavior of pediatric patients with mucopolysaccharidosis II: a longitudinal observational study. Orphanet J. Rare Dis. 2023;18:357. doi: 10.1186/s13023-023-02805-3. - DOI - PMC - PubMed
-
- Muenzer J., Wraith J.E., Beck M., Giugliani R., Harmatz P., Eng C.M., Vellodi A., Martin R., Ramaswami U., Gucsavas-Calikoglu M., Vijayaraghavan S., Wendt S., Puga A.C., Ulbrich B., Shinawi M., Cleary M., Piper D., Conway A.M., Kimura A. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (hunter syndrome) Genet. Med. 2006;8:465–473. doi: 10.1097/01.gim.0000232477.37660.fb. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous